SomnoMed (SomnoMed) Cash And Cash Equivalents : $8.59 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is SomnoMed Cash And Cash Equivalents?

SomnoMed's quarterly cash and cash equivalents declined from Dec. 2022 ($11.39 Mil) to Jun. 2023 ($8.02 Mil) but then increased from Jun. 2023 ($8.02 Mil) to Dec. 2023 ($8.59 Mil).

SomnoMed's annual cash and cash equivalents declined from Jun. 2021 ($16.14 Mil) to Jun. 2022 ($10.99 Mil) and declined from Jun. 2022 ($10.99 Mil) to Jun. 2023 ($8.02 Mil).

SomnoMed Cash And Cash Equivalents Historical Data

The historical data trend for SomnoMed's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomnoMed Cash And Cash Equivalents Chart

SomnoMed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Cash And Cash Equivalents

Get a 7-Day Free Trial

5.35

20.82

16.14

10.99

8.02

SomnoMed Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															12.57	10.99	11.39	8.02	8.59

SomnoMed Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

SomnoMed (OTCPK:SOMNF) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

SomnoMed Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of SomnoMed's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

SomnoMed (SomnoMed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SomnoMed Ltd (OTCPK:SOMNF) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

RJV:Germany SOM:Australia

Address

20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065

Website

https://www.somnomed.com/au

SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.

SomnoMed (SomnoMed) Headlines

From GuruFocus

SomnoMed posts record Q4 and delivers on FY22 revenue guidance

By PRNewswire PRNewswire • 07-26-2022

SomnoMed's North America Q1 revenue growth leads the way

By PRNewswire PRNewswire • 10-28-2022